CC
GRTS

Corton Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Corton Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,852
Closed -$53K – 545
2022
Q1 		$53K Sell
12,852
-8,449
-40% -$44.8K 0.02% 413
2021
Q4 		$274K Buy
+21,301
New +$236K 0.12% 176

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Corton Capital's GRTS Position: Q2 2022 in Review

Corton Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2022, closing a stake of 12,852 shares — an estimated $53K sold.

Corton Capital first reported a position in GRTS in Q4 2021 and held it in 2 quarters. The position peaked at $274K in Q4 2021. 87 funds tracked by Wall St. Rank hold GRTS as of Q2 2022.

  • Corton Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Corton Capital sold 12,852 Gritstone bio, Inc. Common Stock shares in Q2 2022, an estimated $53K.
  • Corton Capital first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Corton Capital's Gritstone bio, Inc. Common Stock position peaked at $274K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2022.

Based on Corton Capital's 13F filing for Q2 2022, filed 15 Aug 2022.